Literature DB >> 26104943

Expert Consensus Contouring Guidelines for Intensity Modulated Radiation Therapy in Esophageal and Gastroesophageal Junction Cancer.

Abraham J Wu1, Walter R Bosch2, Daniel T Chang3, Theodore S Hong4, Salma K Jabbour5, Lawrence R Kleinberg6, Harvey J Mamon7, Charles R Thomas8, Karyn A Goodman9.   

Abstract

PURPOSE/OBJECTIVE(S): Current guidelines for esophageal cancer contouring are derived from traditional 2-dimensional fields based on bony landmarks, and they do not provide sufficient anatomic detail to ensure consistent contouring for more conformal radiation therapy techniques such as intensity modulated radiation therapy (IMRT). Therefore, we convened an expert panel with the specific aim to derive contouring guidelines and generate an atlas for the clinical target volume (CTV) in esophageal or gastroesophageal junction (GEJ) cancer. METHODS AND MATERIALS: Eight expert academically based gastrointestinal radiation oncologists participated. Three sample cases were chosen: a GEJ cancer, a distal esophageal cancer, and a mid-upper esophageal cancer. Uniform computed tomographic (CT) simulation datasets and accompanying diagnostic positron emission tomographic/CT images were distributed to each expert, and the expert was instructed to generate gross tumor volume (GTV) and CTV contours for each case. All contours were aggregated and subjected to quantitative analysis to assess the degree of concordance between experts and to generate draft consensus contours. The panel then refined these contours to generate the contouring atlas.
RESULTS: The κ statistics indicated substantial agreement between panelists for each of the 3 test cases. A consensus CTV atlas was generated for the 3 test cases, each representing common anatomic presentations of esophageal cancer. The panel agreed on guidelines and principles to facilitate the generalizability of the atlas to individual cases.
CONCLUSIONS: This expert panel successfully reached agreement on contouring guidelines for esophageal and GEJ IMRT and generated a reference CTV atlas. This atlas will serve as a reference for IMRT contours for clinical practice and prospective trial design. Subsequent patterns of failure analyses of clinical datasets using these guidelines may require modification in the future.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2015        PMID: 26104943      PMCID: PMC4481325          DOI: 10.1016/j.ijrobp.2015.03.030

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  29 in total

1.  7th edition of the AJCC Cancer Staging Manual: esophagus and esophagogastric junction.

Authors:  Thomas W Rice; Eugene H Blackstone; Valerie W Rusch
Journal:  Ann Surg Oncol       Date:  2010-07       Impact factor: 5.344

2.  Understanding interobserver agreement: the kappa statistic.

Authors:  Anthony J Viera; Joanne M Garrett
Journal:  Fam Med       Date:  2005-05       Impact factor: 1.756

3.  Chemoradiotherapy of locally advanced esophageal cancer: long-term follow-up of a prospective randomized trial (RTOG 85-01). Radiation Therapy Oncology Group.

Authors:  J S Cooper; M D Guo; A Herskovic; J S Macdonald; J A Martenson; M Al-Sarraf; R Byhardt; A H Russell; J J Beitler; S Spencer; S O Asbell; M V Graham; L L Leichman
Journal:  JAMA       Date:  1999-05-05       Impact factor: 56.272

4.  Pathological analysis of clinical target volume margin for radiotherapy in patients with esophageal and gastroesophageal junction carcinoma.

Authors:  Xian-Shu Gao; Xueying Qiao; Fengpeng Wu; Li Cao; Xianli Meng; Zhiming Dong; Xiaoling Wang; Guodong Gao; Tsung-Teh Wu; Ritsuko Komaki; Joe Y Chang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2007-02-01       Impact factor: 7.038

5.  Three-dimensional conformal radiation therapy for esophageal squamous cell carcinoma: is elective nodal irradiation necessary?

Authors:  Kuai-le Zhao; Jin-bo Ma; Guang Liu; Kai-liang Wu; Xue-hui Shi; Guo-liang Jiang
Journal:  Int J Radiat Oncol Biol Phys       Date:  2009-12-11       Impact factor: 7.038

6.  The IASLC lung cancer staging project: a proposal for a new international lymph node map in the forthcoming seventh edition of the TNM classification for lung cancer.

Authors:  Valerie W Rusch; Hisao Asamura; Hirokazu Watanabe; Dorothy J Giroux; Ramon Rami-Porta; Peter Goldstraw
Journal:  J Thorac Oncol       Date:  2009-05       Impact factor: 15.609

Review 7.  EORTC-ROG expert opinion: radiotherapy volume and treatment guidelines for neoadjuvant radiation of adenocarcinomas of the gastroesophageal junction and the stomach.

Authors:  Oscar Matzinger; Erich Gerber; Zvi Bernstein; Philippe Maingon; Karin Haustermans; Jean François Bosset; Akos Gulyban; Philip Poortmans; Laurence Collette; Abraham Kuten
Journal:  Radiother Oncol       Date:  2009-04-15       Impact factor: 6.280

8.  Adenocarcinoma of the esophagogastric junction: the pattern of metastatic lymph node dissemination as a rationale for elective lymphatic target volume definition.

Authors:  Iris Meier; Susanne Merkel; Thomas Papadopoulos; Rolf Sauer; Werner Hohenberger; Thomas B Brunner
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-04-01       Impact factor: 7.038

9.  Phase III trial of trimodality therapy with cisplatin, fluorouracil, radiotherapy, and surgery compared with surgery alone for esophageal cancer: CALGB 9781.

Authors:  Joel Tepper; Mark J Krasna; Donna Niedzwiecki; Donna Hollis; Carolyn E Reed; Richard Goldberg; Krystyna Kiel; Christopher Willett; David Sugarbaker; Robert Mayer
Journal:  J Clin Oncol       Date:  2008-03-01       Impact factor: 44.544

10.  Study to determine adequate margins in radiotherapy planning for esophageal carcinoma by detailing patterns of recurrence after definitive chemoradiotherapy.

Authors:  Michael R Button; Carys A Morgan; Elizabeth S Croydon; S Ashley Roberts; Thomas D L Crosby
Journal:  Int J Radiat Oncol Biol Phys       Date:  2008-08-19       Impact factor: 7.038

View more
  41 in total

1.  Development and Usage of eContour, a Novel, Three-Dimensional, Image-Based Web Site to Facilitate Access to Contouring Guidelines at the Point of Care.

Authors:  Michael V Sherer; Diana Lin; Kartikeya Puri; Neil Panjwani; Zhigang Zhang; James D Murphy; Erin F Gillespie
Journal:  JCO Clin Cancer Inform       Date:  2019-10

2.  Comparison of treatment plans for a high-field MRI-linac and a conventional linac for esophageal cancer.

Authors:  Marcel Nachbar; David Mönnich; Paul Kalwa; Daniel Zips; Daniela Thorwarth; Cihan Gani
Journal:  Strahlenther Onkol       Date:  2018-10-25       Impact factor: 3.621

3.  A comparative study of automatic image segmentation algorithms for target tracking in MR-IGRT.

Authors:  Yuan Feng; Iwan Kawrakow; Jeff Olsen; Parag J Parikh; Camille Noel; Omar Wooten; Dongsu Du; Sasa Mutic; Yanle Hu
Journal:  J Appl Clin Med Phys       Date:  2016-03       Impact factor: 2.102

4.  Motion-compensated FDG PET/CT for oesophageal cancer.

Authors:  Francine E M Voncken; Erik Vegt; Johanna W van Sandick; Jolanda M van Dieren; Cecile Grootscholten; Annemarieke Bartels-Rutten; Steven L Takken; Jan-Jakob Sonke; Jeroen B van de Kamer; Berthe M P Aleman
Journal:  Strahlenther Onkol       Date:  2021-04-07       Impact factor: 3.621

5.  Pathologic complete response (pCR) rates and outcomes after neoadjuvant chemoradiotherapy with proton or photon radiation for adenocarcinomas of the esophagus and gastroesophageal junction.

Authors:  Cristina M DeCesaris; Melanie Berger; J Isabelle Choi; Shamus R Carr; Whitney M Burrows; William F Regine; Charles B Simone; Jason K Molitoris
Journal:  J Gastrointest Oncol       Date:  2020-08

6.  Does Radiation Dose to Gastric Fundus during Neoadjuvant Chemoradiotherapy for Esophageal Carcinoma Have an Impact on Postoperative Anastomotic Leak?

Authors:  Nikhila Radhakrishna; Shyama Prem Sudha; Raja Kalayarasan; Prasanth Penumadu
Journal:  Gastrointest Tumors       Date:  2021-03-17

7.  Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from China.

Authors:  Yuan Tian; Zefen Xiao; Xiao Chang; Wei Deng; Xin Wang; Zongmei Zhou; Jun Yang; Wenling Guo; Miaoling Liu; Xiaolu Qi; Ling Li; Kaixian Zhang; Min Zhang; Yonggang Shi; Ke Liu; Yidian Zhao; Huitao Wang; Zhilong Yu; Jihong Zhang; Lihua Wang; Xueying Qiao; Chun Han; Shuchai Zhu; Ruohui Zhang; Junqiang Chen; Cairong Hu; Fuquan Zhang; Xiaorong Hou; Qingsong Pang; Wencheng Zhang; Gaofeng Li; Hailei Lin; Xinchen Sun; Xiaolin Ge; Caihong Li; Hong Ge; Dingjie Li; Yadi Wang; Na Lu; Xianshu Gao; Shangbin Qin
Journal:  Radiat Oncol       Date:  2021-06-09       Impact factor: 3.481

8.  Incidence and Dosimetric Predictors of Radiation-Induced Gastric Bleeding After Chemoradiation for Esophageal and Gastroesophageal Junction Cancer.

Authors:  Margaret Montovano; Minsi Zhang; Patrick Oh; Maria Thor; Christopher Crane; Ellen Yorke; Abraham J Wu; Andrew Jackson
Journal:  Adv Radiat Oncol       Date:  2021-01-16

9.  Comparison of endoscopically determined gross tumor volume and metabolic tumor volume in esophageal cancer.

Authors:  Tae Hoon Lee; Hyun Gee Ryoo; Reeree Lee; Jin Chul Paeng; Hyunsoo Chung; Hak Jae Kim
Journal:  Medicine (Baltimore)       Date:  2021-06-18       Impact factor: 1.817

10.  Uncertainties in target volume delineation in radiotherapy - are they relevant and what can we do about them?

Authors:  Barbara Segedin; Primoz Petric
Journal:  Radiol Oncol       Date:  2016-05-09       Impact factor: 2.991

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.